Software may be eating the world, but it was hardware-intensive startups that scooped up this week’s largest funding rounds, ...

For whatever reason, I’ve been home a lot recently.

SpyGlass Pharma secures $75 million in Series D funding to enhance its innovative drug delivery platform for long-term ...

SpyGlass Pharma has closed a Series D funding round, raising $75m to advance the company's drug delivery platform to offer ...

SpyGlass Pharma announced today that it closed a $75 million Series D financing round to support its drug delivery platform.

Financing supports SpyGlass Pharma’s platform through the readout of two Phase III pivotal trials ALISO VIEJO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic ...

OK. One last column on the whole “why is my medicine so expensive” thing, and then I am done. Promise.It has come to my ...

The ROW segment may see a 4 percent year-on-year decline. According to a Moneycontrol poll of five brokerage firms, Sun Pharma is expected to reflect continued strength in specialty and chronic ...

Gland Pharma Q4 Results: Pharma company Gland Pharma on Tuesday, May 20, posted a weak set of numbers for the fourth quarter of the financial year 2024-25 (Q4 FY25), recording a single-digit fall ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple myeloma drug into pivotal trials. The candidate in question, an oral p300 ...

India's pharmaceutical sector is experiencing rapid growth, with a 7.8% year-on-year increase in April 2025, driven by strong domestic demand and new product introductions. The country is a ...

Open Payments is one of those databases: It publishes tens of millions of transaction records every year, allowing patients to see how much money their doctors have received from pharma and ...